Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
37.6M
-
Number of holders
-
150
-
Total shares
-
37.2M
-
Shares change
-
-1.03M
-
Total reported value, excl. options
-
$538M
-
Value change
-
-$19M
-
Put/Call ratio
-
9.3
-
Number of buys
-
78
-
Number of sells
-
-73
-
Price
-
$14.44
Significant Holders of NEVRO CORP - Common Stock, par value $0.001 per share (NVRO) as of Q1 2024
162 filings reported holding NVRO - NEVRO CORP - Common Stock, par value $0.001 per share as of Q1 2024.
NEVRO CORP - Common Stock, par value $0.001 per share (NVRO) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.2M shares
of 37.6M outstanding shares and own 99.01% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (3.62M shares), BlackRock Inc. (3.41M shares), VANGUARD GROUP INC (3.17M shares), ArrowMark Colorado Holdings LLC (2.8M shares), FRED ALGER MANAGEMENT, LLC (2.08M shares), Engaged Capital LLC (1.89M shares), BRAIDWELL LP (1.78M shares), D. E. Shaw & Co., Inc. (1.15M shares), STATE STREET CORP (1.09M shares), and Rock Springs Capital Management LP (1.07M shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.